Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Shepard

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos Computational Biology|March 14, 2015
Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancersChristopher DeBoever, Emanuela M Ghia, Peter J Shepard, et al.
Cancer Research|February 21, 2006
Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug developmentErich Koller, Stephanie Propp, Hong Zhang, et al.
Archives of Toxicology|July 16, 2018
Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-SeqAlice Limonciel, Gamze Ates, Giada Carta, et al.
Cell Stem Cell|April 8, 2017
Aberrant DNA Methylation in Human iPSCs Associates with MYC-Binding Motifs in a Clone-Specific Manner Independent of GeneticsAthanasia D Panopoulos, Erin N Smith, Angelo D Arias, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos Computational Biology|March 14, 2015
Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancersChristopher DeBoever, Emanuela M Ghia, Peter J Shepard, et al.
Cancer Research|February 21, 2006
Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug developmentErich Koller, Stephanie Propp, Hong Zhang, et al.
Archives of Toxicology|July 16, 2018
Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-SeqAlice Limonciel, Gamze Ates, Giada Carta, et al.
Cell Stem Cell|April 8, 2017
Aberrant DNA Methylation in Human iPSCs Associates with MYC-Binding Motifs in a Clone-Specific Manner Independent of GeneticsAthanasia D Panopoulos, Erin N Smith, Angelo D Arias, et al.
Pageof 2